company background image
BIEL

BioElectronics OTCPK:BIEL Stock Report

Last Price

US$0.0008

Market Cap

US$19.8m

7D

0%

1Y

-66.7%

Updated

17 Aug, 2022

Data

Company Financials
BIEL fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

BIEL Stock Overview

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide.

BioElectronics Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BioElectronics
Historical stock prices
Current Share PriceUS$0.0008
52 Week HighUS$0.0025
52 Week LowUS$0.0005
Beta0.16
1 Month Change-15.79%
3 Month Change33.33%
1 Year Change-66.67%
3 Year Change-11.11%
5 Year Change14.29%
Change since IPO-99.83%

Recent News & Updates

Shareholder Returns

BIELUS Medical EquipmentUS Market
7D0%-0.4%1.1%
1Y-66.7%-21.1%-9.0%

Return vs Industry: BIEL underperformed the US Medical Equipment industry which returned -20.7% over the past year.

Return vs Market: BIEL underperformed the US Market which returned -8.9% over the past year.

Price Volatility

Is BIEL's price volatile compared to industry and market?
BIEL volatility
BIEL Average Weekly Movement23.2%
Medical Equipment Industry Average Movement9.4%
Market Average Movement7.6%
10% most volatile stocks in US Market17.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: BIEL is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 23% a week.

Volatility Over Time: BIEL's weekly volatility (23%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2000n/aKelly Whelanhttps://www.bielcorp.com

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions.

BioElectronics Corporation Fundamentals Summary

How do BioElectronics's earnings and revenue compare to its market cap?
BIEL fundamental statistics
Market CapUS$19.76m
Earnings (TTM)-US$289.82k
Revenue (TTM)US$1.61m

13.3x

P/S Ratio

-80.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
BIEL income statement (TTM)
RevenueUS$1.61m
Cost of RevenueUS$813.93k
Gross ProfitUS$795.53k
Other ExpensesUS$1.09m
Earnings-US$289.82k

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.00001
Gross Margin49.43%
Net Profit Margin-18.01%
Debt/Equity Ratio-88.3%

How did BIEL perform over the long term?

See historical performance and comparison